At the request of PDFORRA, officials from my Department and the Director of the Defence Forces Medical Branch recently met with PDFORRA to outline the medical policy in relation to the use of malaria chemoprophylaxis in the Defence Forces.
I am advised, as were PDFORRA, that the Defence Forces Medical Policy on the use of malaria chemoprophylaxis (including the use of Lariam) is in line with the United Nations (UN) and World Health Organization (WHO) guidelines.
The use of and the information on medications is kept under ongoing review. There are no plans to withdraw Lariam from the range of anti-malarial medications available to the Defence Forces.